Results 61 to 70 of about 3,573,509 (380)

Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitors [PDF]

open access: yes, 2008
Poster presentation: Purpose of the study To compare the lipometabolic profiles of three double-boosted protease inhibitor (PI) regimens at standard dose, containing saquinavir and ritonavir in combination with lopinavir (LOPSAQ), atazanavir (ATSAQ) or ...
Bickel, Markus   +8 more
core   +1 more source

Evolutionary Multi-Objective Design of SARS-CoV-2 Protease Inhibitor Candidates

open access: yes, 2020
Computational drug design based on artificial intelligence is an emerging research area. At the time of writing this paper, the world suffers from an outbreak of the coronavirus SARS-CoV-2.
A Alhossary   +24 more
core   +1 more source

Osteochondral angiogenesis and increased protease inhibitor expression in OA [PDF]

open access: yes, 2010
SummaryObjectiveNormal cartilage is resistant to vascular invasion and anti-angiogenic protease inhibitors may contribute to its avascular status. We hypothesized that dysregulated expression of four key anti-angiogenic protease inhibitors may contribute
Fransès, R.E.   +3 more
core   +2 more sources

Differential in vitro and in vivo effect of barley cysteine and serine protease inhibitors on phytopathogenic microorganisms [PDF]

open access: yes, 2011
Protease inhibitors from plants have been involved in defence mechanisms against pests and pathogens. Phytocystatins and trypsin/α-amylase inhibitors are two of the best characterized protease inhibitor families in plants.
Cambra Marin, Ines   +5 more
core   +2 more sources

Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

open access: yesJournal of Medicinal Chemistry, 2016
HIV-1 protease inhibitors continue to play an important role in the treatment of HIV/AIDS, transforming this deadly ailment into a more manageable chronic infection.
Arun K. Ghosh   +2 more
semanticscholar   +1 more source

The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure. [PDF]

open access: yes, 2002
We recently reported a new class of inhibitors of the chymotrypsin-like serine protease NS3 of the hepatitis C virus. These inhibitors exploit the binding potential of the S′ site of the protease, which is not generally used by the natural substrates ...
BIANCHI E.   +6 more
core   +1 more source

Proteolysis and Its Control Using Protease Inhibitors in Fish and Fish Products: A Review.

open access: yesComprehensive Reviews in Food Science and Food Safety, 2018
Texture is one of the food quality attributes affecting the consumer's acceptability and the market value. Fish and shellfish undergo weakening or softening of muscle, particularly during extended storage under inappropriate conditions. The phenomenon is
Avtar Singh, S. Benjakul
semanticscholar   +1 more source

HIV-1 Protease: Structural Perspectives on Drug Resistance

open access: yesViruses, 2009
Antiviral inhibitors of HIV-1 protease are a notable success of structure-based drug design and have dramatically improved AIDS therapy. Analysis of the structures and activities of drug resistant protease variants has revealed novel molecular mechanisms
Irene T. Weber, Johnson Agniswamy
doaj   +1 more source

Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2017
The current study was designed to assess the inhibitory activity of Broussonetia papyrifera-derived polyphenols against 3-chymotrypsin-like and papain-like coronavirus cysteine proteases. The isolated compounds were broussochalcone B (1), broussochalcone
Ji-Young Park   +7 more
semanticscholar   +1 more source

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

open access: yesScience, 2020
Promising antiviral protease inhibitors With no vaccine or proven effective drug against the virus that causes coronavirus disease 2019 (COVID-19), scientists are racing to find clinical antiviral treatments.
Wenhao Dai   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy